Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever

被引:134
作者
Bethell, DB [1 ]
Flobbe, K
Phuong, CXT
Day, NPJ
Phuong, PT
Buurman, WA
Cardosa, MJ
White, NJ
Kwiatkowski, D
机构
[1] John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford, England
[3] Ctr Trop Dis, Wellcome Trust Clin Res Unit, Ho Chi Minh City, Vietnam
[4] Dong Nai Paediat Ctr, Bien Hoa, Dong Nai, Vietnam
[5] Univ Limburg, Dept Surg, Maastricht, Netherlands
[6] Univ Malaysia Sarawak, Sarawak, Malaysia
基金
英国惠康基金;
关键词
D O I
10.1086/517807
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dengue shock syndrome is a severe complication of dengue hemorrhagic fever (DHF), characterized by a massive increase in vascular permeability. Plasma cytokine concentrations were prospectively studied in 443 Vietnamese children with DHF, of whom 6 died. Shock was present in 188 children on admission to hospital, and in 71 children it developed later. Contrary to expectations, certain inflammatory markers (interleukin-6 and soluble intercellular adhesion molecule-1) were lower in the group with shock, and this may reflect the general loss of protein from the circulation due to capillary leakage. Only soluble tumor necrosis factor receptor (TNFR) levels showed a consistent positive relationship with disease severity, in patients with suspected DHF without shock, admission levels of sTNFR-75 in excess of 55 pg/mL predicted the subsequent development of shuck, with a relative risk of 5.5 (95% confidence interval, 2.3-13.2). Large-scale release of soluble TNFR may be an early and specific marker of the endothelial changes that cause dengue shock syndrome.
引用
收藏
页码:778 / 782
页数:5
相关论文
共 15 条
  • [1] BOUMA MG, 1994, J IMMUNOL, V153, P4159
  • [2] BOUMA MG, 1997, IMMUNOCHEMISTRY, V2, P181
  • [3] A NITROCELLULOSE MEMBRANE-BASED IGM CAPTURE ENZYME-IMMUNOASSAY FOR ETIOLOGIC DIAGNOSIS OF DENGUE VIRUS-INFECTIONS
    CARDOSA, MJ
    BAHARUDIN, F
    HAMID, S
    HOOI, TP
    NIMMANITYA, S
    [J]. CLINICAL AND DIAGNOSTIC VIROLOGY, 1995, 3 (04): : 343 - 350
  • [4] DENTENER MA, 1993, J IMMUNOL, V150, P2885
  • [5] INCREASED PLASMA-CONCENTRATIONS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN SEPSIS SYNDROME - CORRELATION WITH PLASMA CREATININE VALUES
    FROON, AHM
    BEMELMANS, MHA
    GREEVE, JW
    VANDERLINDEN, CJ
    BUURMAN, WA
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (05) : 803 - 809
  • [6] Grau GE, 1996, LAB INVEST, V74, P761
  • [7] HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
  • [8] HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
  • [9] DENGUE, YELLOW-FEVER, AND RABIES
    HALSTEAD, SB
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (05) : 559 - 563
  • [10] SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-1-BETA (IL-1-BETA) IN DENGUE-INFECTED PATIENTS
    HOBER, D
    POLI, L
    ROBLIN, B
    GESTAS, P
    CHUNGUE, E
    GRANIC, G
    IMBERT, P
    PECARERE, JL
    VERGEZPASCAL, R
    WATTRE, P
    MANIEZMONTREUIL, M
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 48 (03) : 324 - 331